References

  1. Johns Hopkins Coronavirus Resource Center. Coronavirus COVID-19 global cases. The center for systems science and engineering. (2020). https://coronavirus.jhu.edu/map.html
  2. Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015;1282:1-23. doi: 10.1007/978-1-4939-2438-7_1. PMID: 25720466; PMCID: PMC4369385.
  3. Sexton NR, Smith EC, Blanc H, Vignuzzi M, Peersen OB, Denison MR. Homology-Based Identification of a Mutation in the Coronavirus RNA-Dependent RNA Polymerase That Confers Resistance to Multiple Mutagens. J Virol. 2016 Jul 27;90(16):7415-7428. doi: 10.1128/JVI.00080-16. PMID: 27279608; PMCID: PMC4984655.
  4. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6.
  5. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19)
  6. American Society of Clinical Oncology. COVID-19 Patient Care Information. https://www.asco.org/asco-coronavirus-information/care-individuals-cancer-during-covid-19
  7. Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19. Ann Intern Med. 2020 Mar 27:M20-1133. doi: 10.7326/M20-1133. Epub ahead of print. PMID: 32219410; PMCID: PMC7133056.
  8. Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020 Apr 2:S1470-2045(20)30217-5. doi: 10.1016/S1470-2045(20)30217-5. Epub ahead of print. PMID: 32247319.
  9. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff R, Nuhad IK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020 Apr 3. doi: 10.1634/theoncologist.2020-0213. Epub ahead of print. PMID: 32243668.
  10. Russell B, Moss C, George G, Santaolalla A, Cope A, Papa S, Van Hemelrijck M. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence. Ecancermedicalscience. 2020 Mar 27;14:1022. doi: 10.3332/ecancer.2020.1022. PMCID: PMC7105343.
  11. Tey J, Ho S, Choo BA, Ho F, Yap SP, Tuan JKL, Leong CN, Cheo T, Sommat K, Wang MLC. Navigating the challenges of the COVID-19 outbreak: perspectives from the radiation oncology service in Singapore. Radiother Oncol. 2020 Mar 31. doi: 10.1016/j.radonc.2020.03.030. Epub ahead of print. PMCID: PMC7118656.
  12. Rivera A, Ohri N, Thomas E, Miller R, Knoll MA. The Impact of COVID-19 on Radiation Oncology Clinics and Cancer Patients in the U.S. Adv Radiat Oncol. 2020 Mar 27. doi: 10.1016/j.adro.2020.03.006. Epub ahead of print. PMCID: PMC7118653.
  13. Givi B, Schiff BA, Chinn SB, et al. Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic. JAMA Otolaryngol Head Neck Surg.  Published online March 31, 2020. doi:10.1001/jamaoto.2020.0780
  14. Centers for Disease Control and Prevention (CDC), COVD-19, Healthcare Infection Prevention and Control FAQshttps://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-faq.html
  15. World Health Organisation (WHO). Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected. Interim guidance 2020 [Available from: https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected.
  16. S. Lei et al., Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection, EClinicalMedicine (2020), https://doi.org/10.1016/j.eclinm.2020.100331
  17. FACT SHEET FOR HEALTHCARE PROVIDERS. CDC - 2019-nCoV Real-Time RT-PCR Diagnostic Panel Updated: March 15, 2020 https://www.cdc.gov/coronavirus/2019-ncov/downloads/Factsheet-for-Healthcare-Providers-2019-nCoV.pdf
  18. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan W. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. 2020 Mar 11:e203786. doi: 10.1001/jama.2020.3786. Epub ahead of print. PMID: 32159775; PMCID: PMC7066521.